EuroPCR 2023: Late-Breaking Science Video Collection

Published: 18 May 2023

Views:
1838
Likes:
7

Views:
1838
Likes:
7
Share:

Now Playing
Part 3
3 Trials That Will Change Your Practice With Dr Mirvat Alasnag
Mirvat Alasnag

Up Next

1m 5s

Part 4 | Session 1 Dr Lim: Patient Care and Finding Your Passion
D Scott Lim
1m 51s

Part 4 | Session 2 Dr Sandeep Arunothayaraj: Interventional Cardiology and His Advice To Young Investigators
Sandeep Arunothayaraj
1m 45s

Part 4 | Session 3 Dr Sorajja: Why He Chose Cardiovascular Medicine
Paul Sorajja

5m 41s

Part 1 | Session 1 EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions Sandeep Arunothayaraj

6m 12s

Part 1 | Session 2 BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction Antonio Mangieri

3m 15s

Part 1 | Session 3 DRAGONFLY-DMR: Safety and Effectiveness of Dragonfly TMVR System for Mitral Regurgitation D Scott Lim

3m 30s

Part 1 | Session 4 TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation Paul Sorajja

6m 7s

Part 1 | Session 5 EBC MAIN Three-Year Follow Up David Hildick-Smith

4m 59s

Part 1 | Session 6 TVT Registry Analysis: TAVR in Patients with Cardiogenic Shock Abhijeet Dhoble

2m 35s

Part 1 | Session 7 FAME III Three-Year Follow-Up Frederik Zimmermann

29m 21s

Part 2 | Session 1 View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview Joost Daemen, Nicolas M Van Mieghem

30m 41s

Part 2 | Session 2 View from the Thoraxcenter: What's Hot at EuroPCR 23? Joost Daemen, Nicolas M Van Mieghem

Average (ratings)

No ratings

Your rating

Overview

Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.

Hear commentary on the practice-changing trials of EuroPCR 2023 from selected faculty in our Highlights Reviews.

Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of EuroPCR 2023.

More from this programme

Part 1

Expert Interviews

Short, concise overviews of the key data revealed at EuroPCR 2023, focussing on the results and impact on future research.

7 sessions
EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions	Watch now
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction	Watch now
DRAGONFLY-DMR: Safety and Effectiveness of Dragonfly TMVR System for Mitral Regurgitation	Watch now
TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation	Watch now
EBC MAIN Three-Year Follow Up	Watch now
TVT Registry Analysis: TAVR in Patients with Cardiogenic Shock	Watch now
FAME III Three-Year Follow-Up	Watch now

Part 2

View from the Thoraxcenter

In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at EuroPCR 2023.

2 sessions
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview	Watch now
View from the Thoraxcenter: What's Hot at EuroPCR 23?	Watch now

Part 3

Highlights Reviews

Commentary on the top late-breaking trials of EuroPCR 2023, as chosen by selected faculty.

1 session
3 Trials That Will Change Your Practice With Dr Mirvat Alasnag	Watch now

Part 4

Behind the Heart

Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.

3 sessions
Dr Lim: Patient Care and Finding Your Passion	Watch now
Dr Sandeep Arunothayaraj: Interventional Cardiology and His Advice To Young Investigators	Watch now
Dr Sorajja: Why He Chose Cardiovascular Medicine	Watch now

About the episode

EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have an impact on interventional science and clinical practice.

Trials covered in detail include:
EBC TWO Five-Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction
KISS: Provisional Stenting in Bifurcation Lesion: Benefit of Side Branch Intervention

Recorded on-site at EuroPCR 2023, Paris.

Faculty Biographies

Mirvat Alasnag

Director of Catheterization Laboratory

Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).

Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.

Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date,…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.